Sporadic Amyotrophic Lateral Sclerosis clinical trials

Explore recruiting sporadic amyotrophic lateral sclerosis clinical trials.

Recruiting sporadic amyotrophic lateral sclerosis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Sporadic Amyotrophic Lateral Sclerosis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Multiple Ascending Dose Study of LY4256984 in Participants with Sporadic Amyotrophic Lateral Sclerosis

Belgium, Spain, Netherlands, Germany

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

B-cell depletion for the treatment of patients with amyotrophic lateral sclerosis (ALS) - A Randomized, Double-blind, Placebo controlled Pilot Study in Patients with Amyotrophic Lateral Sclerosis for the Evaluation of Efficacy and Safety of B-Cell Depletion with Rituximab (ABCD)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2a, multicenter, randomized, double-blind, placebo-controlled study to evaluate safety, tolerability, pharmacodynamic markers, and pharmacokinetics of AP-101 in patients with familial amyotrophic lateral sclerosis (fALS) and sporadic amyotrophic lateral sclerosis (sALS)

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Phase 1 study to evaluate [18F]ACI-19626 as a potential PET radioligand for imaging TDP-43 inclusions in the brain of patients with suspected TDP-43 proteinopathies compared with healthy controls

Netherlands

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Sporadic Amyotrophic Lateral Sclerosis trials by city

Sporadic Amyotrophic Lateral Sclerosis in Toronto Sporadic Amyotrophic Lateral Sclerosis in Vancouver Sporadic Amyotrophic Lateral Sclerosis in Montreal Sporadic Amyotrophic Lateral Sclerosis in Calgary Sporadic Amyotrophic Lateral Sclerosis in Edmonton Sporadic Amyotrophic Lateral Sclerosis in Ottawa Sporadic Amyotrophic Lateral Sclerosis in Winnipeg Sporadic Amyotrophic Lateral Sclerosis in Quebec City Sporadic Amyotrophic Lateral Sclerosis in Hamilton Sporadic Amyotrophic Lateral Sclerosis in Kitchener Sporadic Amyotrophic Lateral Sclerosis in London Sporadic Amyotrophic Lateral Sclerosis in Halifax Sporadic Amyotrophic Lateral Sclerosis in New York Sporadic Amyotrophic Lateral Sclerosis in Los Angeles Sporadic Amyotrophic Lateral Sclerosis in Chicago Sporadic Amyotrophic Lateral Sclerosis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease